Labs / Assays & in vitro testing
Arcinova
Northumberland, United Kingdom · arcinova.com
GMP · GLP
Arcinova is a specialist CDMO/CRDMO that supports pharmaceutical and biotechnology companies with drug substance, drug product, bioanalysis, isotope labelling, and RNA manufacturing. It operates from Alnwick and Reading in the UK and works on early development programmes from candidate selection through clinical transition.
Their website has a general contact form; we send your quote request through it.
What they offer
Drug substance synthesis & manufacturing
Supports drug substance supply from candidate to early clinical development with solid-state and phase-appropriate analytics.
Drug product services
Develops scalable oral, inhaled, and parenteral formulations and supports progression to first-in-human studies.
Isotope labelling
Produces precision-labelled compounds for pre-clinical and human ADME studies.
Bioanalysis
Quantifies drugs, metabolites, and biomarkers using regulatory-compliant bioanalytical methods and reporting.
CMC regulatory support
Authors IND and IMPD documentation and supports CMC strategy and submission-ready dossiers.
RNA manufacturing
Provides GMP-compliant end-to-end RNA manufacturing for RNA therapeutics development.
Aseptic manufacturing
Manufactures sterile drug products for FIH, ADME, and early clinical studies.
Formulation development
Develops phase-appropriate formulations across oral, parenteral, and radiolabelled dosage forms.
Analytical & microbiological method development & validation
Develops and validates phase-appropriate analytical and microbiological methods for drug substance and drug product work.
Stability & QC testing
Generates stability data using analytical, microbiological, and material science methods.
What they work on
- Modalities
- Small molecule, Peptide, mRNA, Biosimilar
- Species and models
- Class II and III biosafety containment
- Assays and studies
- bioanalytical assays, LC-MS/MS assays, ICP-MS analysis, method development, method validation, stability testing, microbiological testing
- Instruments and platforms
- LC-MS/MS, ICP-MS, UPLC-MS/MS, LC-HR-MS, LC-TRAP-MS, LC-QTOF-MS, LC-ICP-MS/MS, ICP-MS/MS
- Scale and capacity
- 48,000 ft² purpose-built drug product facility, up to 1 million doses from the same machine in 24 hrs
- Therapeutic areas
- RNA therapeutics
- Turnaround
- within 72 hours of sample receipt
- Type
- CRDMO
- Sites
- Alnwick, UK · Reading, UK
- Quality
- GLP · GCP · ICH-M10 · ICH Q3 · IND ready
- Founded
- 2021
Similar labs. Hope Medicine (HopeMed), Novalix, Biotest Facility, Devsynthesis
Found in the UK GLP compliance list (MHRA). Listing built from arcinova.com. Work here? Claim this listing.